What we do
King’s is a leading national and international centre for the diagnosis and treatment of blood cancers.
We are home to the centralised bone marrow transplant (BMT) service for King’s and Guy's and St Thomas's NHS Foundation Trusts. This has the largest BMT programme in the UK and performs more than 160 transplants a year.
We are also an international centre for research into and the treatment of myeloid leukaemias, lymphomas and myeloma, and have the first immune gene therapy programme for leukaemia approved by the Gene Therapy Advisory Committee (GTAC). We were the first hospital in the UK to treat lymphoma patients with CAR T therapy, and have an active CAR programme in lymphoma, leukaemia and myeloma.
As a Centre of Excellence for myelodysplasia we have expertise in matched and unrelated transplants for the treatment of myelodysplastic syndrome (MDS).
Our haemato-oncology service:
- carries out autologous (from the patient's own body) and allogeneic (from a donor) transplants, including haploidentical (half-matched) programmes
- carries out numerous national and international studies, which gives our patients access to innovative treatments
- has a cellular and gene therapy programme for myeloid and lymphoid disorders.
Ground floor, Cheyne Wing, King's College Hospital, Denmark Hill, London, SE5 9RS
- Haematology Clinic Reception: +44 (0)20 3299 5554
Patient Information Leaflets
Conditions we treat
We have a large and active interest in the pathogenesis, manifestations and management of haematological malignancies.
We have the largest bone marrow transplant programme in the UK, performing more than 160 autologous, allogeneic and volunteer-unrelated transplants per year in a dedicated unit, using conventional and cutting-edge conditioning protocols.
We are also a harvest centre for BBMR, the Anthony Nolan Trust (including cord harvest), and licensed by the MHRA for granulocyte harvesting.
Our service has various clinics that deal with secondary, tertiary and quaternary referrals for the following conditions:
- acute and chronic myeloid leukaemia
- high and low grade lymphoma
- chronic lymphocytic leukaemia
- aplastic anaemia
- paroxysmal nocturnal haemoglobinuria (PNH)
- myelodysplastic syndrome
- lymphoproliferative disorders
- plasma cell disorders.
We see local, regional and national referrals. Local patients are seen as new patients and have tests ordered at the unit. Tertiary referrals may come with information supplied by their referring service.
The Laboratory for Molecular Haemato-oncology User Guide gives a range of information including how to request tests, transport samples, and turnaround times. Please also see the Viapath website for more information about laboratories and tests.
What is required before referring a patient
Please ensure relevant blood tests and other investigations are carried out before the appointment.
Booking a patient at King's
GPs should refer via NHS e-referral (e-RS) wherever possible.
Other ways to refer
GPs should refer via e-RS. Other referrers can contact Haematology Clinic Reception on 020 3299 5554. Include all relevant results with the referral.
For GPs: The Adult Haematology Referral Guide for GPs supports GPs in referring patients to haematology. There is also a Quick Referral Guide for GPs that summarises the key points. The guides have been developed jointly by King's and Guy's and St Thomas' NHS Foundation Trust.
For urgent or emergency referrals, please contact the individual consultant’s secretary listed under the Key Clinical Staff tab.
For advice and guidance for urgent or routine referrals, please contact relevant staff listed under the Key Clinical Staff tab. GPs can also use the referrals guides above, e-RS Advice and Guidance, and Consultant Connect.
Key Clinical Staff
|Dr Daniele Avenoso||Consultant in Haematology|
|Dr Stella Bowcock||Consultant Haematologist|
|Mrs Carole Cobain-Patel||Head of Nursing Haematology|
|Dr Christina Cox||consultant|
|Mrs Haili Cui||APheresis Clinical Specialist Nurse|
|Dr Kirsty Cuthill||Consultant Haematologist|
|Mrs Kelly Davis||Senior Anticoagulation Nurse|
|Dr Hugues de Lavallade||Consultant Haematologist|
|Prof Stephen Devereux||Hon Consultant Haematologist|
|Miss Helen Dewhurst||ANP|
|Prof Farzin Farzaneh||Professor of Molecular Medicine|
|Mrs Fiona Gebbie||Clinical Nurse Specialist in Melyoma|
|Mr Helen Gillespie||BMT Co-ordinator CNS|
|Ms Victoria Harris||Clinical nurse specialist|
|Mrs Janet Hayden||Myeloid Clinical Nurse Specialist|
|Miss Sophie Jackson||Genetic Technologist|
|Dr Shireen Kassam||Consultant Haematologist|
|Mr Maj Kazmi||Consultant|
|Ms Laura Kearney||Genetic Technologist|
|Ms Michelle Kenyon||Consultant Nurse (BMT)|
|Dr Pramila Krishnamurthy||Consultant|
|Dr Andrea Kuhnl||Consultant Haematologist|
|Prof Judith Marsh||Consultant Haematologist|
|Mrs Helen Mazzullo||Clinical Scientist|
|Mr Ibrahim Momoh||Clinical Nurse Specialist - PNH|
|Mr Bijan Moshaver||Opersation manager|
|Miss Isabel Sofia Pereira Da Silva Sa||SATO|
|Miss Pilar Perez Abellan||HCPC Registered Biomedical Scientist|
|Dr Kavita Raj||Consultant Haematologist|
|Mrs Gabriella Rennick||Advanced Nurse Practitioner|
|Miss Bibi Reynolds||Haematology Bed Manager|
|Dr Robin Sanderson||Consultant|
|Miss Ashley Sherwood||Advanced Nurse Practitoner|
|Dr Gregory Shields||Consultant Psychiatrist|
|Dr Matthew Streetly||Consultant Haemato-oncologist|
|Miss Elli Wellving||Clinical nurse specialist|
|Miss Lauren Wise||Biomedical Scientist|
|Dr Deborah Yallop||Consultant Haematologist|